語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Animal models for the development of cancer immunotherapy
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Animal models for the development of cancer immunotherapy/ edited by Seng-Lai Tan.
其他作者:
Tan, Seng-Lai.
出版者:
Hoboken, NJ :Wiley, : 2022.,
面頁冊數:
1 online resource.
標題:
Disease Models, Animal. -
電子資源:
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
ISBN:
9781119535331
Animal models for the development of cancer immunotherapy
Animal models for the development of cancer immunotherapy
[electronic resource] /edited by Seng-Lai Tan. - Hoboken, NJ :Wiley,2022. - 1 online resource.
Includes bibliographical references and index.
"There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"--
ISBN: 9781119535331Subjects--Topical Terms:
582981
Disease Models, Animal.
LC Class. No.: SF910.T8 / A55 2022
Dewey Class. No.: 636.089/6994
National Library of Medicine Call No.: QZ 266
Animal models for the development of cancer immunotherapy
LDR
:01562cam a2200325 a 4500
001
1109889
003
OCoLC
005
20221202042454.0
006
m o d
007
cr cnu---unuuu
008
231110s2022 nju ob 001 0 eng
020
$a
9781119535331
$q
(electronic bk.)
020
$a
1119535336
$q
(electronic bk.)
020
$a
9781119535317
$q
(epub)
020
$a
111953531X
$q
(epub)
020
$a
9781119535270
$q
(ePDF)
020
$a
1119535271
$q
(ePDF)
020
$z
9781119535287
$q
(hbk.)
035
$a
1341342966
040
$a
DLC
$b
eng
$c
DLC
$d
YDX
$d
OCLCF
$d
DG1
041
0
$a
eng
050
0 0
$a
SF910.T8
$b
A55 2022
060
0 0
$a
QZ 266
082
0 0
$a
636.089/6994
$2
23
245
0 0
$a
Animal models for the development of cancer immunotherapy
$h
[electronic resource] /
$c
edited by Seng-Lai Tan.
260
$a
Hoboken, NJ :
$b
Wiley,
$c
2022.
300
$a
1 online resource.
504
$a
Includes bibliographical references and index.
520
$a
"There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"--
$c
Provided by publisher.
588
$a
Description based on print version record.
650
2 2
$a
Disease Models, Animal.
$3
582981
650
2 2
$a
Immunotherapy
$x
methods.
$3
654773
650
1 2
$a
Neoplasms
$x
therapy.
$3
581037
650
0
$a
Tumors
$x
Treatment.
$3
678323
700
1
$a
Tan, Seng-Lai.
$3
1100506
856
4 0
$u
https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入